Efficacy of Shen Cao Gan Jiang Tang on Non-severe COVID-19 Patients: A Multicenter, Randomized, Open-Label Clinical Trial.

However, there were seven patients (4.7%) with severe disease in the control group, compared to only one (0.7%) in the SCGJT group, but this difference did not reach statistical significance (p > 0.05), and no deaths were reported (Table 2 ).

also in 111,027 other papers

From the fifth day after randomization, RT-PCR was conducted and showed a decreasing trend in the proportion of SARS-CoV-2 infected individuals in both groups over time.

also in 47,180 other papers